Zap away heart flutters: new Nano-Pulse catheter targets AFib

NCT ID NCT06696170

First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 22 times

Summary

This study is testing a new device called the CellFX Nano-PFA 360 catheter, which uses very short electrical pulses to treat atrial fibrillation (an irregular heartbeat). About 60 adults aged 18 to 75 with paroxysmal atrial fibrillation will receive this procedure. The goal is to see if the device is safe and can successfully restore a normal heart rhythm by blocking faulty electrical signals in the heart.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION PAROXYSMAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hartcentrum Hasselt Research Center /Jessa Hospital

    ACTIVE_NOT_RECRUITING

    Hasselt, Belgium

  • Na Homolce Hospital

    RECRUITING

    Prague, Czechia

    Contact

    Contact

  • Policlinico Tor Vergata Hospital

    RECRUITING

    Roma, Italy

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.